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Abstract 
Purpose: To evaluate the acticonvulsant activity of Cichorium intybus (C. intybus) and Taraxacum 
serotinum (T. serotinum) in maximal electroshock (MES), as well as pentylenetetrazole (PTZ)- and 
strychnine nitrate (STN) - induced seizure models in rats.  
Methods: For each model, 8 groups of Swiss albino rats (n=10) were used. The 1st group was kept as 
control, 2nd as standard (diazepam, 7.5 mg/kg); 3rd - 5th were treated with C. intybus ethanol extract 
(125, 250 and 500 mg/kg); and 6th - 8th treated with T. serotinum extract (125, 250 and 500 mg/kg). 
After 30 min of administration, the rats were exposed to a shock of 150 mA by a convulsiometer, via ear 
electrodes for 2 s (in MES test) or sc injection of PTZ (85 mg/kg) or STN (2.5 mg/kg). Anticonvulsant 
activity was confirmed by abolition of hind limb tonic extension (HLTE) in MES test and by measuring 
the latency to PTZ or STN-induced threshold seizures, and the duration of seizures in the rats. 
Results: In MES model, 500 mg/kg of C. intybus and T. serotinum resulted in complete abolition of 
HLTE in 70 and 50 % of the rats, respectively, compared to 80 % in diazepam-medicated animals. Both 
extracts at 500 mg/kg prolonged latency to seizure onset in PTZ model to 144.7 and 114.7 s, 
respectively (vs 55.2 s in control group; p < 0.05). Both extracts failed to protect rats against STN-
induced seizures. 
Conclusion: C. intybus and T. serotinum possess anticonvulsant effect as they both abolish HLTE 
induced by MES and delay the latency of seizures produced by PTZ. 
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Despite fundamental progress made in the 
treatment of neurological disorders, epilepsy 
remains a significant therapeutic defiance. 
Epilepsy, a disorder of the brain is a major health 
problem that affects 1–2 % of the world 
population [1]. It is characterized by recurrent 
spontaneous seizures, in addition to 
unpredictable and periodic occurrence of a 
transient alteration of behavior due to the 
disordered, synchronous and rhythmic firing of 
populations of brain neurons. It has been 
observed that presently available antiepileptic 
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drugs do not provide cure nor prevent relapse 
and they are often associated with debilitating 
adverse effects [2]. Toxicity, intolerance, and lack 
of efficacy are the limitations of the current 
antiepileptic drugs. The development of new 
pharmacological agents that can overcome these 
barriers has become a major goal in epilepsy 
research. The plant kingdom is a major target in 
the search of new drugs of natural origin to be 
used for protection against this debilitating 
neurological disorder. 
 
Cichorium intybus L. or Chicory is a medicinally 
important plant that belongs to the family 
Asteraceae. The genus Cichorium consists of six 
species with major distribution areas in Europe 
and Asia. Asteraceae is the largest family of 
flowering plants, comprising about 1,100 genera 
and more than 20,000 species. Chicory lives as a 
wild plant on roadsides in its native Europe, and 
in North America and Australia, where it has 
become naturalized. It is known in Turkey as 
catlangaç, çatlangaç süpürgesi, Taşlik Badik out 
and Çıtlak out. Its habitats are roadsides, 
railroads and waste grounds. In traditional 
medicine, all parts of the plant specially root and 
leaves are used as diuretic, laxative, antibilious, 
antipyretic, blood purification and strengthening 
of the stomach [3]. It is also used as an appetizer 
as well as in the treatment of hepatic failure, 
jaundice, intermittent fever and mild states of 
chronic skin diseases. Recent studies have 
found some of the important constituents in 
chicory such as caffeic acid derivatives, 
fructooligosaccharides, flavonoids, inulin, and 
polyphenol [4]. It also contains a bitter glycoside 
named cichorine. The sesquiterpene lactones 
such as lactucin and lactucopicrin were isolated 
from chicory and reported for its antibacterial and 
antimalarial activity [5]. 
 
The genus Taraxacum is a member of the family 
Asteraceae and widely distributed in the warmer 
temperate zones of the Northern Hemisphere. 
The perennial weed has been known since 
ancient times for its curative properties and has 
been utilized for the treatment of various ailments 
such as dyspepsia, heartburn, spleen and liver 
complaints, hepatitis and anorexia [6]. Several 
flavonoids including caffeic acid, chlorogenic 
acid, luteolin, and luteolin 7-glucoside have been 
isolated from plants of the genus Taraxacum [7]. 
T. serotinum plant is known in Turkey as sütlük 
and is considered as one of the vitamin-rich 
plants. The leaves of T. serotinum are used in 
the Turkish folk medicine as cardiotonic [8]. The 
plant is also used as an appetizer and digestant. 
 
Some plants of Asteraceae are used widely in 
Africa and Asia for the treatment of epilepsy. This 
study was undertaken to evaluate the possible 
anticonvulsant activities of C. intybus and T. 
serotinum extracts using different in vivo models 
such as maximal electroshock seizure (MES), as 
well as pentylenetetrazole (PTZ) and strychnine 






Fresh flowering stage aerial parts of Cichorium 
intybus L. and Taraxacum serotinum (Wldst. & 
Kit.) were collected during summer, 2010 from 
Beypazarı-Nallıhan way, Ankara , Turkey and 
Hasanoğlan, surrounding Yeşildere village, 
Ankara, Turkey, respectively. Both plants were 
identified by Prof. Dr. Galip Akaydin and voucher 
specimens (Akaydın 10301 and Akaydın 13430, 
respectively) were deposited at Hacettepe 
University, the Herbarium of Faculty of Education 




Twenty one-day-old Albino rats of either sex 
were obtained from the Animal House of the 
National Research Centre, Cairo, Egypt. Animals 
were maintained under standard conditions of 
temperature (23 ± 1.0 °C), humidity (55 ± 10 %), 
and 12 h light/12 h dark cycle and fed with a 
standard pellet diet (National Company for 
Animals’ diet, Dakahleya, Egypt) with water ad 
libitum. Rats were kept in groups of ten in 
standard polypropylene cages. Animals were 
allowed to acclimatize to the laboratory 
environment for one week before 
experimentation. No rat was used more than 
once for the investigation of the anticonvulsant 
effect of the tested extracts. Animal procedures 
were performed in accordance with the Ethics 
Committee of the National Research Centre and 
followed the recommendations of the Institutes 
for Laboratory Animal Research [9]. 
 
Preparation of plant extract 
 
The collected plants were shade dried and then 
grinded to fine powder. The dried powder of each 
plant (400 g) was extracted by percolation in 70 
% aqueous ethanol with occasional shaking for 
48 h. Percolation was repeated three times, and 
then the ethanolic extracts of each plant were 
combined, filtered and concentrated to dryness 
under reduced pressure at 60 ± 1 °C in a rotary 
evaporator to give the total extracts of C. İntybus 
and T. serotinum. Both extracts were stored in 
Abdel-Rahman et al 
Trop J Pharm Res, October 2015; 14(10): 1831  
 
the refrigerator and aliquot of the concentrations 
were prepared immediately before use. 
 
Acute toxicity (LD50) test  
 
The oral median lethal doses (LD50) of the 
extracts were determined in Albino rats as 
described by Lorke [10]. Briefly, each extract was 
administered orally at different ascending doses 
(50-5000 mg/kg) to groups of three rats each. 
Control animals received the solvent (3 % v/v 
Tween 80 in distilled water) and were kept under 
the same conditions without any treatment. 
Animals were observed for 24 h for signs of 
toxicity and mortality. The LD50 value was 
determined by calculating the geometric means 
of the lowest dose that caused death and the 
highest dose for which the animals survived. 
 
Justification for dose selection  
 
C. İntybus and T. serotinum extracts were 
nontoxic at the dose of 5000 mg/kg. Accordingly, 
experimental doses of 125, 250 and 500 mg/kg 
that are equal to 1/40, 1/20 and 1/10 of the 
highest possible dose tolerated by rats were 
selected for the study. 
 
Screening for anticonvulsant activity 
 
Both the electrically induced seizure model 
(MES) and chemically induced seizure models 
(scPTZ and scSTN) were used to determine the 
anticonvulsant activity of C. İntybus and T. 
serotinum extracts in 21-day-old Albino rats. 
 
Maximal electroshock seizure (MES) test  
 
The MES test was performed on 21-day-old 
Albino rats of either sex by following the method 
of Garg et al [11]. Animals were divided into 8 
groups each consisting of ten rats and treated for 
10 days. Group I received the vehicle (3 % 
Tween 80, orally); group II was allotted for 
standard drug (diazepam, 7.5 mg/kg, ip). Groups 
III, IV and V received C. intybus extract at oral 
doses of 125, 250 and 500 mg/kg, respectively. 
Groups VI, VII and VIII received T. serotinum 
extract at oral doses of 125, 250 and 500 mg/kg, 
respectively. On the 10th day, 30 min after 
administration of the last dose of the vehicle, 
extracts and diazepam, rats were subjected to a 
shock of 150 mA by convulsiometer (ECT unit, 
model 57800, Ugo Basile, Comerio, Italy), 
through ear electrodes for 2 sec. The number of 
animals exhibiting hind limb tonic extension 
(HLTE) seizures and the percentage of animals 
protected against HLTE were recorded. Animals 
in which HLTE response were abolished within 
10 sec after delivery of the electroshock were 
taken as protected rats. The HLTE was judged 
abolished if the extension of hind limb did not 
exceed a 90° angle with the plane of the body. 
 
Pentylenetetrazole (PTZ) and strychnine 
(STN)-induced seizure tests 
 
For each chemoconvulsant, 80 rats were used 
(n=10). Grouping and dosing patterns were 
similar to those stated with MES test. Rats were 
administered the vehicle, diazepam and the test 
extracts for ten days. On the 10th day, 30 min 
after administration of the last dose of the 
vehicle, diazepam and the test extracts, seizures 
were induced in rats by subcutaneous injection of 
PTZ (85 mg/kg, for PTZ-induced seizure test)or 
STN (2.5 mg/kg, for STN-induced seizure test). 
The latency to PTZ or STN-induced threshold 
seizures, the duration of seizures, percentage of 
animals protected against seizures and 
percentage of animals protected against lethality 




Data were expressed as percentage (%) 
protection and mean ± SEM and were analyzed 
by one-way ANOVA followed by Dunnett's test 
for multiple comparisons using the SPSS version 





Acute oral toxicity 
 
The results obtained indicated that C. intybus 
and T. serotinum extracts at oral doses up to 
5000 mg/kg did not produce any symptom of 
acute toxicity and none of the rats died during 24 
h of observation. All animals did not exhibit 
diarrhea, haematuria, restlessness, uncoordi-
nated muscle movements, and respiratory 
distress accordingly; it suggested that oral 
median lethal dose (LD50) of the tested extracts 




Treatment of rats with the ethanolic extracts of C. 
intybus (125 mg/kg) and T. serotinum (125 and 
250 mg/kg), did not produce significant effect 
against seizure induced by MES. They failed also 
to protect the rats against seizure induced by 
PTZ. In addition, both extracts at all tested doses 
failed to protect rats against STN-induced 
seizure. 
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In the maximal electroshock seizure (MES) test, 
100 % of the controlled rats exhibited hind limb 
tonic extensions (HLTE) seizure. Diazepam at 
the dose of 7.5 mg/kg provided 80 % protection 
against MES seizure. In addition, the ethanolic 
extracts of C. intybus and T. serotinum 
demonstrated dose-dependent anticonvulsant 
activity against electroshock-induced HLTE. C. 
intybus extract at the doses of 250 and 500 
mg/kg provided 60 % and 70 % protection, 
respectively while T. serotinum (500 mg/kg) 
provided 50 % protection (Table 1). 
 
PTZ-induced clonic convulsions as well as 
lethality in rats, whereas pretreatment of the rats 
with C. intybus (250 and 500 mg/ kg) and T. 
serotinum (500 mg/ kg) extracts caused 
significant delay in the onset of the seizure as 
well as lethality (Table 2). Both doses of C. 
intybus delayed the latency to PTZ-induced 
threshold seizure to 116.4 ± 6.56 and 144.7 ± 
7.82 s, respectively, compared with normal 
controls (55.2 ± 2.58 s). 
  
In the PTZ induced seizure model, diazepam (7.5 
mg/kg) inhibited the tonic seizures and death 
both at 100 %. In comparison, C. intybus extract 
(250 and 500 mg/kg) showed protection against 
seizure (50 and 60 %, respectively) and mortality 
(60 and 90 %, respectively). While T. serotinum 
(500 mg/kg) showed protection against PTZ 
induced seizure and prevented death both at the 
rate of 50 %. 
 
In this study, it was observed that C. intybus and 
T. serotinum extracts did not produce significant 
anticonvulsant effect against STN-induced 




In screening natural products for  pharmaco-
logical activity, assessment and evaluation of the 
toxic characteristics of a natural product extract, 
fraction, or compound are usually initial steps 
taken. In this study, C. intybus and T. serotinum 
extracts at doses up to 5000 mg/kg had no 
treatment-related signs of toxicity or mortality in 
any of the animals tested during 24 hours of 
observation. The LD50 of C. intybus and T. 
serotinum was therefore estimated to be more 
than 5000 mg/kg. Therefore, C. intybus and T. 
serotinum can be categorized as highly safe 
extracts since substances possessing LD50 
higher than 50 mg/kg b.wt are non-toxic [13]. 
 
 
Table 1: Anticonvulsant activity of C. intybus and T. serotinum extracts in MES-induced seizure in rats 
 
Treatment Dose (mg/kg) 




Control (vehicle) 5 mL/kg 10/10 0 
Diazepam 7.5 2/10 80 
 
C. intybus 
125 9/10 10 
250 4/10 60 
500 3/10 70 
 
T. serotinum 
125 9/10 10 
250 8/10 20 
500 5/10 50 
The results are expressed ratio and percentage (n =10) 
 
Table 2: Anticonvulsant activity of C. intybus and T. serotinum extracts in PTZ-induced seizure in rats 
 

















Control (vehicle) 5 mL/kg 10/10 55.2±2.58 192.5±8.72 0 0 
Diazepam 7.5 0/10 ND ND 100 100 
 
C. intybus 
125 9/10 61.8±3.60 184.2±7.27 10 0 
250 5/10 116.4±6.56* 113.5±4.57* 50 60 
500 4/10 144.7±7.82* 93.2±3.95* 60 90 
 
T. serotinum 
125 9/10 58.2±2.73 185.7±8.16 10 0 
250 8/10 74.6±6.35 172.4±5.64 20 10 
500 5/10 114.7±5.85* 114.4±4.24* 50 50 
The results are expressed as mean ± S.E.M. and %, n = 10 rats/group; * indicate significance compared to 
normal control group at p< 0.05 (Dunnett's test); ND = not determined 
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Table 3: Anticonvulsant activity of C. intybus and T. serotinum extracts in STN-induced seizure in rats 
 


















Control (vehicle) 5 mL/kg 10/10 115.4±6.15 37.6±1.25 0 0 
Diazepam 7.5 0/10 ND ND 100 100 
 
C. intybus 
125 10/10 121.3±6.73 35.6±1.75 0 0 
250 10/10 134.6±6.83 33.2±1.26 0 0 
500 8/10 142.2±6.12 32.3±1.27 20 0 
 
T. serotinum 
125 10/10 120.3±5.37 36.9±1.32 0 0 
250 10/10 127.6±5.75 33.8±1.63 0 0 
500 9/10 136.2±5.33 33.3±1.66 10 0 
The results are expressed as mean ± SEM and %, n =10 rats/group; ND = not determined 
 
According to the chemical labelling and 
classification of acute systemic toxicity 
recommended by the Organization for Economic 
Cooperation and Development (OECD), the 
ethanolic extracts of C. intybus and T. serotinum 
were assigned class 5 status (LD50 > 
5000 mg/kg), which is  the lowest toxicity class. 
In addition, substances with LD50 values higher 
than 5000 mg/kg by oral route are regarded as 
being safe or practically nontoxic [14]. 
  
Despite the diversity of models that could 
potentially be used to screen for anticonvulsant 
activity, the maximal electroshock seizure (MES) 
and the subcutaneous pentylenetetrazole (PTZ)-
induced seizure models remain ‘Gold standards’ 
in the early stages of testing. In the present 
investigation, the tested extracts were subjected 
to a screening in anticonvulsant assays including 
MES, PTZ and strychnine (STN)-induced seizure 
tests in 21-day-old Albino rats. Development of a 
new compound for the treatment of epilepsy 
relies heavily on the use of predictable animal 
models.   
 
The present results indicate that the ethanolic 
extracts of C. intybus (250 and 500 mg/kg) and 
T. serotinum (500 mg/kg) have anticonvulsant 
activities in the MES and PTZ-induced seizure 
tests. It has often been stated that anticonvulsant 
drugs that prevent tonic extension of MES act by 
blocking spread of seizure whereas drugs that 
either prevents or delays seizure of PTZ, act by 
elevating the seizure threshold [15]. 
 
In the maximal electroshock seizure (MES) test, 
100 % of the controlled rats exhibited hind limb 
tonic extensions (HLTE) seizure. The MES is a 
standard procedure that evaluates the ability of 
the testing materials to protect against HLTE. 
Ibrahim et al [16] stated that the seizure features 
in MES are similar for all laboratory animals and 
human except for the time scale. The standard 
drug diazepam (7.5 mg/kg) and the ethanolic 
extracts of C. intybus (250 and 500 mg/ kg) and 
T. serotinum (500 mg/ kg) exhibited  significant 
anticonvulsant activity and offered 80, 60, 70, 
and 50 % protection against electroshock-
induced HLTE, respectively. In the MES, 
protection against HLTE predicts the 
anticonvulsant activity of the tested agents. 
Moreover, protection against HLTE in MES-
induced seizure indicates the capability of C. 
intybus and T. serotinum extracts to either stop 
or to slow down the discharge of the seizure 
within the brain stem substrate [17]. 
 
Seizure of MES can be blocked either by 
inhibiting the voltage-dependent Na+ channels or 
by blocking glutamatergic excitation mediated by 
the N-methyl-D-aspartate (NMDA) receptors [18]. 
Since C. intybus and T. serotinum extracts 
showed anti-epileptic activity in the MES, they 
may act by inhibiting the voltage-dependent Na+ 
channels or by blocking the glutamatergic 
neurotransmission mediated by NMDA receptors. 
In addition, various classes of phytoconstituents 
such as flavonoids, phenols, and terpenes have 
been reported to possess anticonvulsant activity 
[19]. Accordingly, the significant anticonvulsant 
activities of C. intybus and T. serotinum extracts 
may be due to the presence of many potent 
compounds such as flavonoids [7].  
 
In PTZ test, diazepam (7.5 mg/kg), C. intybus 
(250 and 500 mg/kg) and T. serotinum 
(500 mg/kg) extracts exhibited a significant 
anticonvulsant effect. C. intybus was found to be 
more effective than T. serotinum. These results 
provide evidence that both extracts possesses 
anticonvulsant activity. The ability of both 
extracts to delay the onset of convulsions and/or 
shorten the duration of convulsions was 
considered an indication of anticonvulsant 
activity. 
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It was suggested that compounds which are 
effective in suppression of PTZ-induced clonic 
seizures partially overlapped with the group of 
compounds effective against MES [20]. In this 
regard, diazepam was found to be more effective 
against PTZ than MES seizures which agrees 
with the idea that PTZ is a GABA-A receptor 
antagonist. Accordingly, PTZ produces seizures 
by blocking the major GABAergic inhibitory 
pathways in the central nervous system [21]. 
Standard antiepileptic drugs such as diazepam 
are thought to produce their effects by enhancing 
GABA-mediated inhibition in the brain [22]. 
Moreover, activation of the N-methyl-d-aspartate 
(NMDA) receptors is also involved in the initiation 
and propagation of PTZ-induced seizures [23]. In 
this regard, drugs that block glutamatergic 
excitation mediated by NMDA receptors have 
demonstrated anticonvulsant activity against 
PTZ-induced seizures [22]. Seizures induced by 
PTZ can also be blocked by reducing T-type 
Ca2+ currents [24]. Therefore, the anticonvulsant 
activities of C. intybus and T. serotinum extracts 
against PTZ seizures might be due to an 
enhancement on the release of the inhibitory 
neurotransmitter GABA in the central nervous 
system, inhibiting T-type Ca2+ currents or 
blocking the glutamatergic neurotransmission 
mediated by NMDA receptors, which were not 
tested in this study.  
 
The convulsive action of strychnine is due to 
interference with postsynaptic inhibition mediated 
by glycine, an important inhibitory transmitter to 
motor neurons and interneurons in the spinal 
cord [25]. In this study, it was observed that both 
extracts did not produce significant 
anticonvulsant effect against STN-induced 
seizures as compared to control, suggesting their 
inability to interact with the glycine-mediate 




C. intybus and T. serotinum extracts show 
marked protective activities against PTZ-induced 
and maximal electroshock seizures, but are 
ineffective against STN-induced convulsion. 
Further phytochemical studies are required to 
isolate and identify the active molecule(s) 




1. Visweswari G, Prasad K, Chetan P, Lokanatha V, 
Rajendra W. Evaluation of the anticonvulsant effect of 
Centella asiatica (gotu kola) in pentylenetetrazol-
induced seizures with respect to cholinergic 
neurotransmission. Epilepsy & Behavior 2010; 17: 
332-335. 
 
2. Belcastro V, Striano P, Gorgone G, Costa C, Ciampa C, 
Caccamo D, et al. Hyperhomocysteinemia in epileptic 
patients on new antiepileptic drugs. Epilepsia 2010; 
51: 274–279.  
3. Zaman R, Basar SN. A Review Article of Beekhe Kasni 
(Cichorium intybus) its Traditional uses and 
Pharmacological Actions Res. J. Pharmaceutical Sci. 
2013; 2(8): 1-4. 
4. Kocsis I. Effects of chicory on pancreas status of rats in 
experimental dyslipidemia, Volume, Acta Biologica 
Szegediensis 2003; 47: 143-146.  
5. Bischoff T, Nguyen-Dinh P, Arefi A, Laurantos M, Kelley 
C, Karchesy Y. Antimalarial activity of Lactucin and 
Lactucopicrin sesquiterpene lactones isolated from 
Cichorium intybus L. J Ethnopharmacol 2004; 95: 
455-457. 
6. Schütz K, Carle R, Schieber A. Taraxacum--a review on 
its phytochemical and pharmacological profile. J 
Ethnopharmacol 2006; 107: 313-23. 
7. Williams CA, Goldstone F, Greeham J. Flavonoids, 
cinnamic acids and coumarins from the different 
tissues and medicinal preparations of Taraxacum 
officinale. Phytochemistry 1996; 42: 121–127. 
8. Yazıcıoğlu E, Alpınar K. An investigation on medicinal 
and edible plants of Trabzon”. Ege Univ Ecz Fak Der 
1993; 1: 89-98.  
9. Committee for the Update of the Guide for the Care and 
Use of Laboratory Animals, Institute for Laboratory 
Animal Research. Guide for the care and use of 
laboratory animals, 8th ed, The National Academies 
Press, Washington, DC, USA, 2011. 
10. Lorke DA. A new approach to practical acute toxicity 
testing. Arch Toxicol 1983; 54: 275–287.  
11. Garg N, Chandra T, Jain A, Kumar A. Synthesis and 
evaluation of some new substituted benzothiazepine 
and benzoxazepine derivatives as anticonvulsant 
agents. Eur J Med Chem 2010; 45: 1529-1535. 
12. Ishola IO, olayemi SO, Yemitan OK, Ekpemandudiri NK. 
Mechanisms of anticonvulsant and sedative actions 
of the ethanolic stem-bark extract of Ficus sur Forssk 
(Moraceae) in rodents. Pak J Biol Sci 2013; 16: 1287-
1294. 
13. Buck WB, Osweiter GD, Van Gelder AG. Clinical and 
Diagnostic Veterinary Toxicology. Iowa: Kendall/hunt 
Publishing Co; 1976. p. 5211. OECD (Organization 
for Economic Cooperation and Development), 2001. 
The OECD 423 Guideline for Testing of Chemicals 
Acute Oral Toxicity-Acute Toxic Class Method, Paris, 
France. 
14. Kennedy GL, Ferenz RL, and Burgess BA, “Estimation of 
acute oral toxicity in rats by determination of the 
approximate lethal dose rather than the LD50,” 
Journal of Applied Toxicology 1986; 6(3): 145–148 
15. Bum EN, Schmutz M, Meyer C, Rakotonirina A, Bopelet 
M, Portet C, et al. Anticonvulsant properties of the 
Abdel-Rahman et al 
Trop J Pharm Res, October 2015; 14(10): 1835  
 
methanolic extract of Cyperus articulatus. J 
Ethnopharmacol 2001; 76: 145–150. 
16. Ibrahim G, Abdulmumin S, Musa K, Yaro A. 
Anticonvulsant Activities of Crude Flavonoid Fraction 
of the Stem Bark of Ficus sycomorus (Moraceae). J 
Pharmacol Toxicol 2008; 3: 351-356. 
17. Nagaraja T, Mohamood R, Krishna V, Thippeswamy B, 
Veerapur V. Anticonvulsant activity of Erythrina 
mysorensis bark extract in an animal model of 
epilepsy. J Pharmacol Pharmacother 2012; 3: 62–64. 
18. Luszczki JJ, Lucyna A, Czuczwar SJ. 1-methyl-1, 2, 3, 4-
tetrahydroisoquinoline enhances the anticonvulsant 
action of carbamazepine and valproate in the mouse 
maximal electroshock seizure model. Neuro 
pharmacol 2006; 50: 133–142. 
19. Ali M, Chaudhary N. Ficus hispida Linn.: A review of its 
Pharmacognostic and ethnomedicinal properties. 
Pharmacogn Rev 2011; 5: 96–102.  
20. Meldrum BS. Do preclinical seizure models preselect 
certain adverse effects of antiepileptic drugs. 
Epilepsy Res 2002; 50: 33-40. 
21. Gupta G, Afzal M, David S, Verma R, Candaswamy M, 
Anwar F. Anticonvulsant activity of Morus alba and its 
effect on brain gamma-aminobutyric acid level in rats. 
Pharmacog Res 2014; 6: 188-189. 
22. MacDonald RL, Kelly KM. Anti-epileptic drug 
mechanisms of action. Epilepsia 1995; 36: S2–S12.  
23. Yudkoff M, Daikhin Y, Nissim I, Horyn O, Luhovyy B, 
Lazarow A, et al. Short-term fasting, seizure control 
and brain amino acid metabolism. Neurochem Int 
2006; 48: 650-656. 
24. Meldrum BS Update on the mechanism of action of 
antiepileptic drugs. Epilepsia 1996; 37: S4–S11.  
25. Kuno M, Weakly JN. Quantal components of the 
inhibitory synaptic potentials in spinal motor neurons 
of cat. J Physiol 1972; 224: 287–303. 
 
